Vol. 52, No. 1, 2009 - Alpha Chi
Vol. 52, No. 1, 2009 - Alpha Chi
Vol. 52, No. 1, 2009 - Alpha Chi
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
40<br />
Optimism of DNA Vaccines<br />
for HIV<br />
By ABHISHEK SATISHCHANDRAN<br />
University of the Sciences in<br />
Philadelphia<br />
Pennsylvania Kappa<br />
Philadelphia, Pennsylvania<br />
Abhishek Satishehandran was selected an H. Y. Benedict<br />
Fellow for 2008-09 but declined.<br />
Abstract<br />
In an effort to improve DNA vaccine immune potency, electroporation has emerged<br />
as a method of delivery of plasmids to target tissues. However, few studies have examined<br />
the use of this technology to deliver plasmid vaccines to the skin, particularly in large<br />
animal models. We have studied the effect of electroporation on DNA vaccine potency<br />
and plasmid delivery using skin as a target tissue. Initially, we delivered plasmid GFP<br />
through the intradermal/subcutaneous (ID) route in a pig model where we found that high<br />
plasmid concentrations resulted in improved gene expression. In a macaque model, we<br />
observed higher cellular and humoral responses to a DNA vaccine encoding HIV gag and<br />
env antigens and molecular adjuvant IL-12, with electroporation (ID+EP) compared to ID<br />
injection alone. ELISpot analysis demonstrated a TH1 mediated response with significantly<br />
higher levels of CD8 memory cells. These results serve to support the potential of ID+EP as<br />
an effective immunization approach in larger animal models.<br />
39